3 ms·
Money and perverse incentives. Clinical trials are expensive, and rapamycin can't be patented. My guess is that, some time in the future, a pharma company will
by GordonS 4y ago
Money and perverse incentives.
Clinical trials are expensive, and rapamycin can't be patented. My guess is that, some time in the future, a pharma company will produce and patent an analogue, and then there will be trials.